DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Appeal No. 7097 of 2026 filed by Surendra Champalaji Jain

SEBI 23 hrs ago·16 Oct 2026, 2:31 pm

Company SEBI

A significant legal appeal has been filed by Surendra Champalaji Jain, which is currently being heard by the Supreme Court. This case, Appeal No. 7097 of 2026, is a matter of public record and is being processed through the country's highest judicial authority. The specific details of the case are not publicly disclosed in the provided information.

For the broader market, this development is currently viewed as a neutral event. While the filing of a Supreme Court appeal is a serious matter, its impact on the overall market sentiment or individual stock prices is not immediately apparent from the available data. Investors should await further clarification from the court or official company statements regarding the nature of this appeal.